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Reprogramming of somatic cells to induced pluripo-
tent stem cells (iPSCs) holds enormous promise for
regenerativemedicine. To elucidate endogenous bar-
riers limiting thisprocess,wesystematicallydissected
human cellular reprogramming by combining a
genome-wide RNAi screen, innovative computational
methods, extensive single-hit validation, and mecha-
nistic investigation of relevant pathways and net-
works. We identify reprogramming barriers, including
genes involved in transcription, chromatin regulation,
ubiquitination, dephosphorylation, vesicular trans-
port, and cell adhesion. Specific a disintegrin and
metalloproteinase (ADAM)proteins inhibit reprogram-
ming, and thedisintegrindomain ofADAM29 is neces-
sary and sufficient for this function. Clathrin-mediated
endocytosis can be targeted with small molecules
and opposes reprogramming by positively regulating
TGF-b signaling. Genetic interaction studies of endo-
cytosis or ubiquitination reveal that barrier pathways
can act in linear, parallel, or feedforward loop archi-
tectures to antagonize reprogramming. These results
provide a global view of barriers to human cellular
reprogramming.INTRODUCTION
Cells generally become committed to increasingly differentiated
fates during normal development, but experimental paradigms
for cellular reprogramming have shown that differentiation is
reversible. Initial methods for reprogramming included somatic
cell nuclear transfer to enucleated oocytes (Gurdon et al.,1958) or fusion with pluripotent stem cells (Tada et al., 1997),
both of which were technically difficult to dissect at the mecha-
nistic level. The finding that overexpression of a key transcription
factor leads to fibroblast-to-muscle transdifferentiation (Davis
et al., 1987) suggested that perhaps other cell-fate transitions
could similarly be induced. The recent discovery that combina-
tions of transcription factors can reprogram somatic cells to
induced pluripotent stem cells (iPSCs) has transformed stem
cell research and holds enormous promise in regenerative med-
icine (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu
et al., 2007). Understanding the process of reprogramming may
also shed light on events that take place during cellular transfor-
mation in cancer (Daley, 2008; Ramalho-Santos, 2009). How-
ever, due to the low efficiency and protracted nature of the pro-
cess, the mechanisms that underlie the generation of iPSCs
remain poorly understood.
Recent studies have revealed that reprogramming to the iPSC
state is a multistep process involving large-scale changes in the
transcriptional and epigenetic states of somatic cells along the
path to pluripotency (Buganim et al., 2012; Polo et al., 2012).
Importantly, the somatic cell is not a tabula rasa and expresses
genes that antagonize reprogramming, as has been shown for
tumor suppressors (p53, INK4a/ARF, LATS2) (Kawamura et al.,
2009; Qin et al., 2012; Zhao et al., 2008) and H3K9 methyl-
transferases (SETDB1, SUV39H, EHMT2) (Chen et al., 2013). In
addition, focused RNAi screens have revealed other pathways
that act as barriers to reprogramming, such as TGF-b signaling
(Samavarchi-Tehrani et al., 2010), H3K79 methylation by
DOT1L (Onder et al., 2012), or protein ubiquitination (Buckley
et al., 2012). These findings suggest that other critical barriers
to reprogramming are likely to exist, but no genome-wide func-
tional screen has yet been carried out in mouse or human iPSC
generation.
RNAi provides a powerful technique for exploiting a cell’s
endogenous machinery for mRNA degradation to obtain selec-
tive gene knockdown. Well-based genome-wide RNAi screens,Cell 158, 449–461, July 17, 2014 ª2014 Elsevier Inc. 449
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where cells are transfected in separate wells with small pools or
individual small interfering RNAs (siRNAs), have been carried out
successfully, including for the identification of genes that regu-
late human embryonic stem cell (hESC) self-renewal and plurip-
otency (Chia et al., 2010). However, the throughput of this
approach is limited, particularly in the context of iPSC genera-
tion, because of the low reprogramming efficiency. An alterna-
tive to well-based screens yielding much higher throughput is
a pooled short hairpin RNA (shRNA)-based screen combined
with next-generation sequencing (NGS). This approach has a
significantly larger dynamic range and has enabled genome-
wide screens at an unprecedented scale (Bassik et al., 2013;
2009). However, the extraction of robust biological information
from genome-wide screen data is still challenging: the problems
of false-positive hits caused by off-target effects, false-negative
hits caused by ineffective RNAi, and variance in sequencing
depth can limit reliability.
We use ultracomplex EXPANDed pooled shRNA libraries to
report a genome-wide screen for barriers to human cellular re-
programming. We introduce a multiobjective optimization tech-
nique for analyzing NGS-based shRNA screen data and combine
ourmethodwith systems-level meta-analyses and in vitro exper-
iments to discover critical barriers to reprogramming genome
wide. Our integrative approach identifies 956 genes predicted
to act as barriers to reprogramming, including genes involved
in transcription, chromatin regulation, ubiquitination, dephos-
phorylation, vesicular transport, and cell adhesion. We mecha-
nistically dissect the roles of disintegrin proteins and clathrin-
mediated endocytosis as reprogramming barriers and show
that barriers from different pathways interact and can have
combinatorial effects to antagonize reprogramming. The results
are compiled into an online resource (http://song.igb.illinois.edu/
ipsScreen/), allowing researchers to browse, query, and visu-
alize the analysis.
RESULTS AND DISCUSSION
Genome-wide shRNA Libraries and NGS Enable an
Unbiased Screen for Barriers to Reprogramming
We sought to implement a robust and unbiased screen for bar-
riers to human iPSC generation. We used a recently described
method (Bassik et al., 2009) to perform a genome-wide shRNA
library screen targeting 19,527 human genes with an average
coverage of 30 independent shRNAs per gene. Human BJ
fibroblasts were coinfected with lentivirus expressing these
shRNAs along with OCT4, SOX2, KLF4, c-MYC (4F), and p53
RNAi (p53i). We chose to add p53i because it has been shown
to enhance reprogramming efficiency (Kawamura et al., 2009;
Zhao et al., 2008). Moreover, data from a pilot screen demon-Figure 1. A Genome-wide RNAi Screen Identifies Known and Novel Re
(A) Design of the genome-wide RNAi screen in human iPSC generation.
(B) Positive control genes consisting of known barriers identified from the literatu
(miRNAs known to enhance reprogramming efficiency) are enriched in TRA-1-81+
for these genes. The statistical significance was measured by a hypergeometric
(C) Each dot on the graph is a gene. The x axis shows the number of distinct active
level d on a log scale; this summarizes the read-count odds ratios of all active shRN
coded toward red. The top 1% most significant genes are denoted by stars. Exastrate that p53i increases the sampling rate of fully reprog-
rammed cells and, hence, improves sensitivity in the detection
of reprogramming barriers (Figure S1A available online). Impor-
tantly, all of our downstream hit validation was done in the
absence of p53i (see below). Following the appearance of
colonies with iPSC characteristics on day 28, we fluorescence-
activated cell sorting (FACS) purified the transduced cells for
TRA-1-81, a marker of fully reprogrammed human iPSCs (Inter-
national Stem Cell Initiative et al., 2007). Integrated shRNAs
were then recovered and identified by PCR amplification from
genomic DNA of both the TRA-1-81+ and TRA-1-81 cell popu-
lations and quantified by NGS (Figure 1A).
The relative frequency of reads mapping to a given shRNA in
TRA-1-81+ compared to TRA-1-81, expressed as an odds ratio
q, estimates the positive effect size of that shRNA on reprog-
ramming and, thus by inference, the negative effect size of its
targeted gene as a potential reprogramming barrier. We call
an shRNA active if it has greater odds of being sequenced in
TRA-1-81+ compared to TRA-1-81, i.e., if q > 1 with sufficient
coverage. To assess gene-wise collective shRNA activity levels
and to quantify the negative effect size of a given gene on reprog-
ramming, we combined the log-transformed odds ratios for
all active shRNAs targeting a gene into a single statistic using a
random-effects model. The combined statistic, d, controls for
variance in knockdown efficiency and variance in sequencing
depth-of-coverage by estimating them separately from the
data. We then developed a gene-ranking algorithm based on
multiobjective optimization (Handl et al., 2007). This technique
simultaneously maximizes collective shRNA activity and the
number of distinct active shRNAs. The result is a gene ranking
that controls for off-target effects, ashighly rankedgenesarepre-
cisely the ones that demonstrate a reproducible effect
across multiple shRNAs enriched in the TRA-1-81+ population.
To assign statistical significance to gene ranks, we computed p
values using a permutation test with 5,000 permutations of the
read counts. False discovery rates (FDRs) were computed based
on library swap to adjust for multiple-hypothesis testing. We
compared this multiobjective optimization algorithm, which we
call HitSelect, with existing methods, such as RIGER (Luo et al.,
2008) and RSA (Ko¨nig et al., 2007), and found that HitSelect
has greater sensitivity and specificity and is less prone to off-
target effects (Figure S1B). This approach generated 956 TRA-
1-81+ screen hits at the 5% significance level, corresponding to
an FDR of 7% (Extended Experimental Procedures andData S1).
A Genome-wide Screen Confirms Known Barriers to
Reprogramming
To validate our screen, we used as positive controls previously
identified gene barriers, as well as the experimentally validatedgulators of Human iPSC Generation
re and the experimentally validated targets of miR-17, miR-200, and miR-372
. Shown are the medians of the distributions of collective shRNA activity levels
test.
shRNAs targeting the gene. The y axis represents the collective shRNA activity
As targeting a given gene. Genes with greater statistical significance are color-
mples of known barriers or enhancers of reprogramming are indicated.
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targets of microRNAs (miRNAs) known to enhance reprogram-
ming efficiency. Known barrier genes show significant activity
levels in TRA-1-81+ compared to TRA-1-81 (Figures 1B and
1C). Specifically, we identified 26 barrier genes whose knock-
down has been previously shown to enhance the efficiency of
reprogramming, including genes associated with tumor suppres-
sion (CDKN2B), epithelial-to-mesenchymal transition (TGFBR2),
heterochromatin (EHMT2, MECP2, RBL2, SMARCC2), and
extracellular matrix and adhesion (ARHGAP26, RHOC, CD44)
(Figure 1C and Table S1). These positive controls are significantly
enriched in the TRA-1-81+ population (Figure 1B). Targets of
miRNAs known to enhance human reprogramming efficiency,
such as miR-17, miR-200, and miR-372 (Gregory et al., 2008; Li
et al., 2011; Subramanyam et al., 2011), also show significant en-
richments in the TRA-1-81+ population (Figure 1B). As negative
controls, we used control coding sequences represented in the
library (GFP, ampicillin resistance, or luciferase), a random gene
list, or validated targets of miR-218, a known tumor suppressor
not linked to reprogramming. These controls all show weak me-
dian activity (below d= 1) and statistically insignificant enrichment
in the TRA-1-81+ population (Figure 1B). Overall, these data
indicate that our approach is well validated by the successful
identification of previously reported barriers to reprogramming.
Thiswork focuses on genes that act as barriers to reprogramming
for two main reasons: (1) they can be easily knocked down to
improve the efficiency of iPSC generation, providing straightfor-
ward single hit validation; (2) a search for shRNAs enriched
in the TRA-1-81 population is complicated by the high heteroge-
neity of that population, which is not the case in the TRA-1-81+
population. Nevertheless, we also identified shRNAs for mul-
tiple known positive regulators of reprogramming enriched
in the TRA-1-81 population, including OCT4, SOX2, NANOG,
PRDM14, CHD1, PARP1, KDM2A, KDM2B, and KDM3B
(Figure 1C).
Analysis of Screen Hits Identifies Ubiquitination, Cell
Adhesion/Motility, and Endocytosis Pathways as
Putative Barriers to Reprogramming
We took an integrated approach to identifying barrier pathways
and prioritizing genes for downstream validation. We clustered
the 956 TRA-1-81+ screen hits by Interpro protein domain,
Gene Ontology (GO) cellular component, and GO biological pro-
cess annotations via DAVID (Huang et al., 2009a). The most
frequently annotated protein domain is ‘‘WD40 repeat conserved
site’’ (Figure 2A). This domain often serves as a substrate for pro-
tein-protein interactions, and the WD40 annotation cluster con-
tains multiple ubiquitin-conjugating enzymes and ligases. The
importance of the ubiquitination pathway is highlighted by the
recent finding that the E3 ligase F box andWD40 domain protein
7 (FBXW7) functions as a barrier to reprogramming in mouse
(Buckley et al., 2012). FBXW7 is also a hit in our screen and is
part of the WD40 annotation cluster. Using GeneMANIA (Zuberi
et al., 2013) to aggregate published genetic interaction data,
we identified multiple screen hits documented to interact with
FBXW7 (Figure 2B). Thus, the role of ubiquitination as a barrier
to reprogramming may be conserved (see below, Figure S3).
Also enriched among screen hits are annotations associated
with cell adhesion and secretion, as well as adhesion-related452 Cell 158, 449–461, July 17, 2014 ª2014 Elsevier Inc.extracellular protein domains (Figure 2). The most statistically
significant protein domain annotation cluster is ‘‘Protocadherin.’’
Protocadherins are the largest mammalian subfamily of cadher-
ins and have been implicated in cell adhesion and signal trans-
duction. Gene network analysis reveals that there is a dense
colocalization subnetwork of protocadherins among screen
hits (Figure 2B). There are also a large number of proteins con-
taining a ‘‘fibronectin type III’’ domain, as well as a significant
number of metallopeptidases. Several members of the metallo-
peptidase cluster are ADAM proteins. Thesemolecular functions
are likely related to the fact that the most enriched biological
process term is ‘‘Cell adhesion.’’ Thus, pathways mediating
cell adhesion and extracellular matrix interactions are likely to
contain barriers to reprogramming (see below, Figure 4).
Lastly, screen hits showed a significant enrichment for func-
tional annotations related to endocytosis (Figure 2). This enrich-
ment occurs across all three annotation categories. The second
most frequently annotated biological process is ‘‘Vesicle-
mediated transport.’’ Moreover, the largest cellular component
annotation clusters include multiple compartments of the endo-
cytic pathway, such as ‘‘Cytoplasmic vesicle,’’ ‘‘Lysosome,’’ and
‘‘Vacuole.’’ Together, this analysis suggests that endocytosis-
mediated trafficking is a barrier to reprogramming (see below,
Figure 5).
We also examined published time-course data on gene
expression and chromatin marks from reprogramming experi-
ments in mouse. In particular, we considered two recent data
sets where secondary mouse embryonic fibroblasts (MEFs)
were reprogrammed by dox-inducible expression of 4F (Goli-
pour et al., 2012; Polo et al., 2012). Both groups analyzed
the gene-expression profiles of intermediate populations dur-
ing reprogramming, whereas Polo et al. additionally profiled
H3K4me3 and H3K27me3 genome wide. A key feature of both
experimental designs was a strategy to enrich intermediate pop-
ulations for cells with the potential to give rise to iPSCs. Interest-
ingly, our re-analysis of these data sets reveals that functional
annotations associatedwith cell adhesion, motility, and extracel-
lular matrix interactions are overrepresented among genes
downregulated during the course of reprogramming in the Polo
et al. data (Figure S2A). Furthermore, in the data of Golipour
et al., there is significant enrichment for annotations associated
with endocytosis in genes downregulated as reprogramming
proceeds (Figure S2B). Thus, several of the pathways implicated
as barriers by our functional analysis in human reprogramming
have expression patterns consistent with such a role during
the course of mouse reprogramming.
Taken together, our integrative analysis indicates that path-
ways associated with ubiquitination, cell adhesion/motility, and
endocytosis are putative reprogramming barriers. Other poten-
tial barriers include genes with roles in transcription, chromatin
regulation, and dephosphorylation (Figure 2).
Single-GeneAnalyses Validate ReprogrammingBarriers
from Multiple Pathways
To assesswhether genes and pathways enriched in the 956 TRA-
1-81+ hits truly represent reprogramming barriers, we subjected
23 genes to rigorous validation. In addition to genes related
to ubiquitination (UBE2D3, UBE2E3, RNF40), ADAM family
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Figure 2. An Integrated Resource Identifies Barrier Pathways to Reprogramming
(A) Screen hits, significant at the 5% level, were clustered by over-represented GO biological process, GO cellular component, and Interpro protein domain
annotations using the DAVID functional analysis tool. Shown are the clusters with the five highest enrichment scores. Each cluster is represented by the most
frequently occurring annotation term. On the y axis is the number of genes in each cluster. The p value shown was obtained by using Fisher’s method to combine
DAVID assigned p values for individual annotation terms within a cluster.
(B) Gene functional annotations, aggregated via DAVID, were compiled into an interactive tree-map, available online (http://song.igb.uiuc.edu/ipsScreen/docs/
david_treemap.html). All genes shown are screen hits at the 5% significance level. Gene lists for subclusters were analyzed for network structure. This identified
several gene networks and subclusters. (1) A genetic interaction network for the ubiquitin ligase FBXW7. This network documents that FBXW7 can directly and
indirectly interact with multiple screen hits from a variety of pathways. (2) A dense network of protocadherins. Two genes are connected with an edge if their
expression correlates across tissue types. (3) Genetic interaction networks for ADAM family proteins. (4) A subcluster enriched for endocytosis functional
annotations.
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Figure 3. Single-Gene Validation of Reprog-
ramming Barriers
(A) Individual knockdown of screen hits in different
pathways increases the efficiency of human iPSC
generation. The number of iPSC colonies was
counted 25 days after infection of human BJ fi-
broblasts with 4F control, 4F with nonsense (NS)
shRNA control, or 4F with the two most highly
active shRNAs targeting the indicated gene. Error
bars represent SD compared to 4F +NS. *p < 0.05;
**p < 0.01; ***p < 0.001.
(B) Reduction in the levels of gene expression
achieved by shRNA constructs was confirmed by
qRT-PCR.genes (ADAM7, ADAM21, ADAM29), and endocytosis (ARSD,
SLC17A5, DRAM1), we also tested protein tyrosine phospha-
tases (PTPRJ, PTPRK, PTPN11), chromatin regulators (ATF7IP,
ARID4A, CENPB, MED19), transcription factors (TTF1, TTF2,
TMF1, T), and miscellaneous others (RPL30, PLCE1, INPP5K).
For each gene, we chose the two most highly active shRNAs
from the screen and performed single-gene validation of the
knockdowneffect on reprogramming.RNAi for 20out of 23genes
tested (ahit validationof 87%) leads to significant increases in iPS
colony count compared with nonsense (NS) shRNA control (Fig-
ure 3A). The fold increase in reprogramming efficiency ranges
from 1.5 to 4.2, which is comparable with previous studies of
knockdown of reprogramming barriers, including p53/p21 (Ka-
wamura et al., 2009; Zhao et al., 2008), LATS2 (Ohi et al., 2011),
DOT1L, and SUV39H1 (Onder et al., 2012). Knockdown of genes
by shRNAs was confirmed by RT-PCR (Figure 3B).
We next present further validation and mechanistic dissection
of the ubiquitin, cell adhesion andmotility, and endocytosis path-
ways. To facilitate exploration of the entire screendata,we imple-454 Cell 158, 449–461, July 17, 2014 ª2014 Elsevier Inc.mented our integrative analysis into a
publicly available website. This resource
combines the RNAi screen data from
this study with a large collection of pub-
lished genetic and epigenetic data, func-
tional annotation analysis, gene interac-
tion network analysis, and gene kinetics
during reprogramming (http://song.igb.
illinois.edu/ipsScreen/). Researchers are
able to query, browse, and visualize this
data collection.
The Ubiquitin Pathway Is a Barrier
to Reprogramming
Fbxw7, an E3 ubiquitin ligase, was
recently described as a barrier to mouse
iPSC generation (Buckley et al., 2012).
Our systems approach confirms and ex-
tends these findings to a much broader
network of genes in human reprogram-
ming. A variety of conjugating enzymes
(UBE2D3, UBE2E3), ubiquitin ligases
(RNF40, FBXW7, NEDD4, MARCH3),
and deubiquitination enzymes (USP9X,OTUB2) are targeted in the TRA-1-81+ population (Figure S3A
and Data S2). Single-gene validation shows that knocking
down UBE2D3, UBE2E3, or RNF40 individually significantly in-
creases reprogramming efficiency compared to NS shRNA con-
trol, validating their functional role in reprogramming (Figure 3).
We confirmed that iPSCs generated with RNF40 shRNAs
express, in addition to TRA-1-81, the pluripotency markers
NANOG, SSEA3, and SSEA4 at the protein level (Figure S3B)
and express mRNAs of endogenous pluripotency factors at
levels similar to those in hESCs (Figure S3C). We further show
that RNF40i increases reprogramming efficiency without accel-
erating cell expansion rates (Figure S3D). Finally, we show that
inhibition ofmultiplemembers of the ubiquitin pathway increases
the protein levels of the reprogramming factor OCT4 (Fig-
ure S3E), in support of previous mouse studies (Buckley et al.,
2012). These results reveal that the previously reported role of
the ubiquitin pathway as a reprogramming barrier in mouse is
conserved in human and demonstrate the power of our systems
approach to expand upon the pathways identified.
Cell Adhesion and Motility in Reprogramming
Genes involved in thecontrolled turnover of actin filament needed
for cell motility are enriched for screen hits (Figure 4A and Data
S2). Actin, coronin, and RHOC, factors needed for filament
assembly, branching, and disassembly, are all significant hits
in the screen. Moreover, several of the screen hits, including
MMP14, ADAM7, ADAM21, and ADAM29, have well-docu-
mented interactions with the extracellular matrix. Knockdown
of ADAM7, ADAM21, or ADAM29 individually significantly in-
creases human iPSC generation efficiency (Figure 3), with the
most notable effect seen for ADAM29.Weconfirmedby immuno-
fluorescence and qRT-PCR that iPSCs generated with ADAM29
shRNAs express high levels of several pluripotency markers,
comparable to levels in hESCs (Figures 4B and 4C). In addition,
ADAM29i does not increase iPSC generation efficiency by accel-
erating cell expansion rates (Figure 4D). ADAM29 knockdown at
both mRNA and protein levels and the consequential enhance-
ment of reprogramming efficiency were confirmedwith two inde-
pendent shRNAs (Figures S4A–S4C). Moreover, we found that
overexpression of ADAM29 significantly reduces reprogram-
mingefficiency (Figure 4E) anddecreases hESCcolony formation
efficiency (Figure S4D), indicating that ADAM29 impedes both
establishment and maintenance of the pluripotent state. To
study the mechanism of ADAM29 as a reprogramming barrier,
we mutated the metalloprotease and disintegrin domains of
ADAM29 and overexpressed the altered proteins during reprog-
ramming. Mutation of the disintegrin domain, but not the metal-
loprotease domain, abolishes the adverse effect of ADAM29
on reprogramming efficiency (Figures 4E and 4F). Remarkably,
we found that adding a short synthetic peptide corresponding
to the disintegrin loop of ADAM29 to the culture medium, but
not a mutated peptide, significantly reduces iPSC colony forma-
tion efficiency (Figure 4G).
These data demonstrate that specific ADAM proteins are
potent reprogramming barriers and that the disintegrin domain
is necessary and sufficient for their activity during reprogram-
ming. Disintegrin was originally identified from snake venom
metalloprotease, which inhibits blood coagulation and is known
to regulate integrin-dependent cell adhesion. Multiple reports
document the interaction between the ADAM disintegrin domain
and integrins, and the specificity of this interaction is mediated
by a tripeptide motif in the disintegrin domain (Figure S4E) (Cal-
vete et al., 2005; Igarashi et al., 2007). Interestingly, the screen
hits that belong to the ADAM family, ADAM7, ADAM21, and
ADAM29, all have an ECD tripeptide motif (Figure S4F), which
can inhibit specific integrin dimers including those containing
a6. During reprogramming, parental fibroblasts predominantly
express integrin a5, which is not targeted by the ECD motif (Cal-
vete et al., 2005), whereas iPSCs/ESCs express high levels of in-
tegrin a6 (Figure 4H). Integrin a6 is a component of the laminin
receptor, and in turn laminin is important for maintaining self-
renewal of hESCs and iPSCs (Rodin et al., 2010). Together, these
findings suggest that ECD-containing ADAM proteins may
antagonize an integrin switch that occurs during reprogramming
to pluripotency, a model that deserves further exploration.
Notably, both ADAM7 and ADAM29 are often found mutated in
melanoma (Wei et al., 2011), suggesting that ADAM dysfunction
may also contribute to cellular transformation in certain cancers.Endocytosis Is a Barrier to Reprogramming
To obtain a global view of the negative effect size of the endocy-
tosis pathway on reprogramming, we aggregated all screen-hit
genes with endocytosis-related GO biological process annota-
tions (DataS2).Remarkably,multiple screenhitswereassociated
with a variety of components of the endocytic pathway: receptor-
targeting ubiquitin ligases (MARCH3, RNF40, NEDD4); themedi-
ator of vesicle transport, clathrin (CLTA); plasma-membrane
remodeling and early-endosome fusion genes (EHD2, RABEP1);
and endosomal/lysosomal surface proteins (MCOLN1, VPS25,
ARSD, HSPA8, SCARB2, SLC17A5, DRAM1) (Figure 5A and
Data S2). Interestingly, NEDD4 has been reported to ubiquitinate
cell-surface receptors for lysosomal degradation (Persaud et al.,
2011), suggesting a potential crosstalk between the endocytosis
and ubiquitin pathways during reprogramming.
As validation of these findings, we found that knocking down
DRAM1, SLC17A5, or ARSD individually with shRNAs leads to
a significant increase in iPSC generation relative to NS shRNA
control (Figure 3). We also used small molecules to inhibit the
endocytosis pathway. We found that two clathrin-specific inhib-
itors, Pitstop1 and Pitstop2, can dramatically increase reprog-
ramming efficiency, whereas structurally related controls (von
Kleist et al., 2011) have no effect (Figure 5B). Furthermore,
Pitstop2 can also increase iPSC generation efficiency when
episomal vectors are used to reprogram human dermal fibro-
blasts (HDFs) (Figure S5A). Therefore, the effect of Pitstop is
independent of the retroviral infection used in standard reprog-
ramming methods or specific fibroblast lines. We confirmed
that iPSCs generated with Pitstop2 express mRNA and protein
levels of pluripotency markers similar to those of hESCs (Fig-
ure 5D). In addition, Pitstop2 does not affect cell expansion rates
during iPSC generation (Figure S5B). These data demonstrate
that clathrin-mediated endocytosis is a barrier to reprogram-
ming. Inhibitors of endocytosis may thus be added to the panel
of small molecules that enhance reprogramming efficiency.
Endocytosis functions as a master organizer of signaling cir-
cuits by modulating the abundance of receptors, their ligands,
and downstream effectors at different membrane compart-
ments. We sought to further probe the mechanism by which
endocytosis acts as a reprogramming barrier. Treatment of cells
with Pitstop2 at different time points post-infection with 4F re-
vealed that endocytosis acts at an early stage of reprogramming
(Figure 5E). During that stage, reprogramming cells must un-
dergo a mesenchymal-epithelial transition (MET) (Samavarchi-
Tehrani et al., 2010; Subramanyam et al., 2011), and we found
that Pitstop2 upregulates the epithelial marker E-cadherin at
day 12 of reprogramming (Figures S5C and S5D). Of note, it
has been shown that clathrin-mediated endocytosis positively
regulates TGF-b signaling by recycling the receptors (Scita and
Di Fiore, 2010), and TGF-b signaling is a known barrier to reprog-
ramming that inhibits MET (Samavarchi-Tehrani et al., 2010;
Subramanyam et al., 2011). In support of a role for the endocy-
tosis pathway in TGF-b signaling, we found that Pitstop2
inhibits phosphorylation and activation of SMAD2/3, in
particular SMAD2, during reprogramming (Figure S5C). Using
GeneMANIA, we found that the endocytosis and TGF-b signaling
pathways can interact at multiple levels (Figure S5E). Members
of the TGF-b pathway, such as MAPK3 and SMAD2, are alsoCell 158, 449–461, July 17, 2014 ª2014 Elsevier Inc. 455
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Figure 4. ADAMs Are a Barrier to Reprogramming and Act via Their Disintegrin Loop Domain
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screen hits as reprogramming barriers (Figure S5E). Importantly,
in the presence of the TGF-b inhibitor SB431542, Pitstop2 does
not further decrease the level of phosphorylated SMAD2/3 (Fig-
ure 5F), nor does it further increase iPSC generation efficiency
(Figure 5G). Taken together, these data indicate that clathrin-
mediated endocytosis antagonizes reprogramming via a linear
positive interaction with the TGF-b signaling pathway.
Given the observation that inhibition of endocytosis is unable
to synergize with inhibition of TGF-b signaling to increase
reprogramming efficiency, we tested the effect of combining
Pitstop2 with RNAi for members of other barrier pathways. In
contrast to TGF-b signaling, we found that Pitstop2 can further
enhance the iPSC generation efficiency of cells treated with
UBE2E3i, RNF40i, ADAM29i, SLC17A5i, PTPN11i, ATF7IPi, or
TTF2i (Figure 5H). The interaction of Pitstop2 with the lysosomal
protein SLC17A5 (also known as SIALIN) suggests that the lyso-
somal subpathway could have additional effects on reprogram-
ming unrelated to TGF-b signaling. Remarkably, when ADAM29i,
ATF7IPi, and Pitstop2 are combined together, reprogramming
efficiency can be elevated by up to 15-fold (Figure 5H). These
data indicate that endocytosis can act in parallel with other
barriers, including the ubiquitination and ADAM pathways, to
antagonize reprogramming.
Identification of Feedforward Loops between
Reprogramming Barriers
To further explore potential interactions between validated re-
programming barriers, we searched the literature for experi-
ments where one of the barrier genes significantly changed at
the transcriptional level (t test p value < 0.05) after RNAi against
a second barrier gene. Using GeneMANIA, we also aggregated
evidence of tissue-specific coexpression of barrier genes and
identified common barrier-gene protein domains. In the resulting
barrier gene interaction network (Figure 6A, thin edges), RNF40
stands out as a hub (i.e., it has both the highest ‘‘betweenness’’
and ‘‘closeness’’ centralities). We verified these interactions in
human BJ fibroblasts and found that RNF40i induces both pos-
itive and negative effects on the expression of other barrier
genes. RNF40i leads to significant increases in the expression
of ADAM29, PTPN11, TTF2, TMF1, and MED19. RNF40i also in-
duces a significant downregulation of SLC17A5, PTPRJ, and
CENPB (Figure 6A, thick arrows and 6B). Transcriptional effects
of RNF40i likely result from its role in regulating the levels of tran-
scription factors such as OCT4 (Figure S3E) and in ubiquitinating
H2B, a histone mark involved in transcriptional elongation and
stem cell differentiation (Karpiuk et al., 2012). Thus, inhibition
of a reprogramming barrier can alter the expression of other bar-
riers in unexpected ways. We next tested the effect of combining(C) 4F + ADAM29i-induced iPSCs express endogenous pluripotency markers at
(D) Growth curves of fibroblasts infected with 4F, 4F + nonsense (NS), and 4F
substantially alter total cell numbers during the first 13 days of reprogramming. E
(E) ADAM29 overexpression reduces reprogramming efficiency, and the disinteg
fibroblasts overexpressing wild-type (WD) or mutated ADAM29 (H333A in the a
disintegrin domain) were induced to pluripotency by 4F.
(F) Overexpression of wild-type or mutated ADAM29 was confirmed by western
(G) ADAM29 disintegrin loop peptide reduces reprogramming efficiency. Huma
disintegrin loop peptide (100 mg/ml) was added. A peptide with substitutions of t
(H) hESCs H9 express higher levels of integrin a6 and lower levels of integrin a5RNF40i with RNAi for other barriers with which RFN40 interacts
at the expression level (Figure 6B). RNF40i together with
PTPN11i, MED19i, SLC17A5i, or PTPRJi produces combinato-
rial effects on reprogramming efficiency (Figure 6C). These
data suggest that different barrier pathways interact in dynamic
feedforward loops (FFLs) that can be classified as either
coherent or incoherent and are thought to provide noise filtering
and response delay capabilities to stabilize cell types (Mangan
and Alon, 2003). As examples of coherent FFLs with an OR-
gate integration, RNF40 positively regulates the other barrier
genes SLC17A5 and PTPRJ. This kind of network motif can sta-
bilize cells against transient fluctuating signals and can delay the
response to removing the source repressor, which corresponds
to RNF40 in our case. Thus, even though knockdown of RNF40
attenuates the second barrier’s expression, the residual amount
of the second barrier can still partially suppress reprogramming
without RNF40; as a result, simultaneous RNAi against the sec-
ond barrier itself drastically relieves the suppression of reprog-
ramming by the FFL as a whole (Figure 6D). Incoherent FFLs
with an OR-gate integration have not been studied extensively
to date, but we found that such network motifs can also inhibit
reprogramming. For example, RNF40 represses the other barrier
genes PTPN11 and MED19, so that knockdown of RNF40 alone
aberrantly upregulates PTPN11 and MED19, acting as a built-in
compensatory suppressionmechanism against reprogramming.
In this case, a persistent knockdown of RNF40 may only tran-
siently lower the barrier against reprogramming because the
subsequent derepression of PTPN11 and MED19 can help raise
back the barrier. However, the dampening of the increase in re-
programming efficiency that could result from this derepression
of a second barrier can be relieved via knockdown of the second
gene (Figure 6D). The FFLswith OR-gate integration thus provide
partial redundancy in cell-fate control, and removing the redun-
dancy with multiple RNAi manifests itself in the observed combi-
natorial knockdown effect (Figure 6C). Barriers can of course
interact in multiple ways, not just at the transcriptional level.
Nevertheless, the FFLs identified here contribute to revealing
some of the complex interactions between barrier pathways.
Taken together, our genetic interaction studies reveal that barrier
pathways can act in linear, parallel (Figure 5), or FFL (Figure 6) ar-
chitectures to antagonize reprogramming and show that iPSC
generation efficiency can be greatly increased by simultaneous
targeting of different reprogramming barriers.
PERSPECTIVE
We use an ultracomplex EXPANDed shRNA library to report the
application of a genome-wide screen to the process of human
cellular reprogramming to pluripotency. Our integrative studysimilar levels to 4F iPSCs and ESCs.
+ RNF40i, counted on days 0, 4, 8, and 13 post-infection. RNF40i does not
rror bars represent SD.
rin domain is critical for the barrier function of ADAM29 in reprogramming. BJ
ctive site of the metalloprotease domain; E461A and ECD461 deletion in the
blotting. Tubulin was used as loading control.
n BJ fibroblasts were infected with 4F. Four days later, a synthetic ADAM29
he three critical residues (ECD) was used as controls.
and b1 compared with BJ fibroblasts.
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Figure 6. Genetic Interactions between
RNA40 and Other Reprogramming Barriers
(A) In this barrier-gene network, nondirectional
interactions (colored edges) were identified via
a literature search, and genetic interactions
were inferred from knockdown experiments. We
consider gene A to interact with gene B if B’s
expression changes significantly (t test p value <
0.05) after the knockdown of A (red edges). Genes
sharing common protein domains (blue edges),
and genes that are coexpressed in the same
tissue type (purple edges), were aggregated via
GeneMANIA. Directional interactions (thick black
edges) were identified in human fibroblasts from
knockdown experiments shown in (B).
(B) RNF40i affects the expression of other barrier
genes. qRT-PCR was performed in BJ fibroblasts
infected with nonsense (NS) shRNA control or
shRNAs against RNF40.
(C) The net effects on reprogramming efficiency of
simultaneous knockdown of RNA40 and each
of the other barrier genes shown exceed the effect
of knocking down either gene alone.
(D) RNF40 forms coherent and incoherent feed-
forward loops in the barrier-gene network.reveals multiple pathways as reprogramming barriers, including
ubiquitination, endocytosis, cell adhesion, interaction with extra-
cellular matrix, dephosphorylation, and transcription. Moreover,
we found that different barrier pathways interact in complex
combinatorial ways to antagonize reprogramming to the iPSC
state. The data are implemented as a fully searchable integrative
online resource to facilitate other studies of reprogramming.
Our genome-wide RNAi screen provides a systematic
approach to interrogate iPSC generation. Several key aspects
underlie the successful identification of the reprogramming bar-
riers reported here: (1) the high (30 shRNAs) per-gene coveragecolonies were counted. Pitstop1 Neg and Pitstop2 Neg, compounds structurally related to Pitstop1 and Pits
endocytosis (von Kleist et al., 2011), were used as controls.
(C) 4F + Pitstop2 iPSCs show strong immunostaining for pluripotency markers NANOG, SSEA3, and SSEA4
(D) 4F + Pitstop2 iPSCs express endogenous pluripotency markers at levels similar to those of 4F iPSCs an
(E) Endocytosis acts as a barrier at an early stage of reprogramming. Human BJ fibroblasts were infected with
points indicated.
(F) Pitstop2 and TGF-b inhibitor SB431542 (SB, 2 mM) lead to a decrease in pSMAD2/3 levels by western bl
(G) Both Pitstop2 and SB431542 (days 2–14) increase human iPSC generation efficiency. However, when com
(H) Pitstop2 further enhances reprogramming efficiency upon knockdown of multiple other barriers.
Cell 158, 449–of the library reduces off-target effects
in hit selection; (2) using NGS for screen
readout provides a large dynamic range;
(3) a multiobjective optimization algorithm
with greater sensitivity and specificity,
and less prone to off-target effects than
existing methods, helps reduce false-
positive hits; 4) systems-level analyses
combining large-scale integration of
public data with independent functional
validation assays elucidate functional
pathways. Benefiting from these aspects,
our screen has a scale of 600,000shRNAs tested and a hit validation rate of 87%, whereas previ-
ous genome-wide shRNA/siRNA screens tend to have lower
scales (average < 40,000) and average < 50% success rates
(Table S2).
More generally, our work provides a model for combining a
genome-wide screen with large-scale data mining in contexts
other than iPSC generation. Our preliminary findings indicate
that some of the pathways identified may represent barriers to
the induction of stem-like phenotypes in other cellular and dis-
ease processes. We applied our deconvolution method to a
genome-wide screen for barriers against the proliferation oftop2, respectively, but lacking the ability to inhibit
. Scale bar, 300 mm.
d ESCs.
4F. Pitstop2 was added to the medium at the time
otting. Tubulin was used as loading control.
bined together, no additional increase is observed.
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ovarian carcinoma stem cells (Tan et al., 2013). Cross-refer-
encing our iPSC screen hits with the hits in carcinoma stem cells
found 35 overlapping genes at the 5% significance level, and
DAVID functional analysis identified transcription factors, cell
membrane proteins, and ubiquitin pathway genes to be enriched
in these hits (Figure S6). Of note, RNF40 was detected in both
screens. Also enriched in both screens is arginine methyltrans-
ferase PRMT1, previously discussed as part of the FBXW7
interaction network (Figure 2B). Thus, our platform provides an
integrative approach for identifying pathways that may act as
barriers beyond the setting of reprogramming to pluripotency,
including in cancer. We further anticipate that this approach
will be useful in the dissection of direct lineage reprogramming
and may reveal shared and unique aspects of different reprog-
ramming paradigms.
EXPERIMENTAL PROCEDURES
Pooled shRNA Libraries
The design method for generating ultracomplex EXPANDed shRNA libraries
targeting the human genome has been previously described (Bassik et al.,
2009, 2013). In brief, the library contains approximately 30 independent
shRNAs per gene for all human protein-coding genes (19,527 in total), for a to-
tal of600,000 shRNAs, hence the term ‘‘ultracomplex.’’ The full list of shRNA
sequences present in the library is available upon request. Pooled sequences
coding for the shRNAs were cloned downstream of a U6 promoter in a modi-
fied pSicoR lentiviral vector containing aCMV-Puro-T2A-mCherry cassette. All
vectors were pooled to generate one lentiviral library representing the 600,000
shRNAs. The entire pooled library was then used to generate lentiviruses at the
UCSF ViraCore.
RNAi Screen in Human iPSC Generation
Human primary newborn foreskin (BJ) fibroblasts were seeded at 630,000 cells
per 15 cm dish the day before infection. Sixteen 15 cm dishes were used in
total for the whole library screen, to represent 50 cells per shRNA. Cells
were infected with concentrated retroviruses (Harvard Gene Therapy Initiative)
leading to the overexpression of OCT4, SOX2, and KLF4 (multiplicity of infec-
tion [moi] = 10) and c-MYC (moi = 1) (4F), in combination with a lentivirus ex-
pressing an shRNA against p53 (moi = 1) (Zhao et al., 2008) and the lentiviral
shRNA library (moi = 3). On day 28 after infection, cells were trypsinized,
live TRA-1-81 (MAB4381, Millipore) staining was performed, and TRA-1-81+
and TRA-1-81 populations were isolated by FACS (FACSAria II, BD).
Bioinformatic Analyses
TRA-1-81+/TRA-1-81 differential shRNA effect size was estimated by read-
count odds-ratio. shRNA effect sizes were summarized gene wise using a
random effects model. Gene ranking was performed using multiobjective opti-
mization, with collective shRNA effect size and the number of distinct shRNA
as criteria. Significance was assessed using a permutation test, and library
swap was used to control for false discovery in multiple hypothesis testing
(Extended Experimental Procedures). Functional annotations were analyzed
via DAVID (Huang et al., 2009a), and gene interaction networks constructed
via GeneMANIA (Zuberi et al., 2013) and Cytoscape. Betweenness centrality
is defined as the number of shortest paths through the network that pass
through a given node. Closeness centrality is defined as the inverse of the
sum of all shortest-path distances, from a given node, to all other nodes in
the network.
Single-Gene Validation
For gene knockdown, the two most enriched shRNAs against each gene from
the screen data were cloned into the lentiviral vector pSicoR downstream of a
U6 promoter. Each shRNA was cloned into a separate pSicoR-CMV-Puro-
T2A-GFP lentiviral vector. Viruses inducing the expression of two shRNAs
against the same gene were combined together with 4F before infecting cells,460 Cell 158, 449–461, July 17, 2014 ª2014 Elsevier Inc.unless otherwise indicated. Table S3 includes the target sequences of all
shRNAs used for follow-up experiments. For gene overexpression, cDNA
was cloned into the lentiviral vector pGAMA downstream of an EF1a promoter.
Mutations were generated using QuickChange (Agilent) according to the
manufacturer’s instructions. On days 20–28 after infection, live Tra-1-81
(MAB4381, Millipore) staining was performed, and iPSC colonies were
counted. All reprogramming experiments were performed in triplicates, and
error bars represent SD. *p < 0.05; **p < 0.01; ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, four tables, and two data files and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2014.05.040.
AUTHOR CONTRIBUTIONS
M.R.-S. and J.S.S. directed the project. H.Q. and M.R.-S. developed the
experimental design with participation from R.J.L. and M.T.M; R.J.L., E.M.L.,
and M.T.M. developed and produced the RNAi libraries; H.Q., L.B., and P.T.
carried out the bench experiments; A.D. and J.S.S. developed and carried
out the statistical and bioinformatic analyses, with initial input from W.P.;
H.Q., A.D., J.S.S., and M.R.-S. wrote the manuscript.
ACKNOWLEDGMENTS
We are grateful to Robert Blelloch, Keith Mostov, and Zena Werb for critical
reading of themanuscript, JonathanWeissman,Martin Kampann, andMichael
Bassick for discussions and help with library generation, Nikki Shariat for input
on the experiment design, Xiaoyin Wang for virus production, Fong Ming Koh
for providing the pGAMA vector, Charles Nicolet and Henriette O’Geen for
support on NGS, and Tara Rambaldo and Michael Kissner for support with
FACS. This work was supported by NWO Rubicon grant 825.06.030 and
Veni grant 916.10.138 to R.J.L.; the UCSF Program for Breakthrough Biomed-
ical Research and NIH grants 1U01CA168370 and R01 GM80783 to M.T.M.;
NIH R01CA163336 and Sontag Foundation Distinguished Scientist Award to
J.S.S.; and CIRM grant RB4-06028 and NIH Director’s New Innovator Award
DP2OD4698 to M.R.-S. E.M.L. is an employee of Agilent Technologies.
Received: September 5, 2013
Revised: March 5, 2014
Accepted: May 27, 2014
Published: July 17, 2014
REFERENCES
Bassik, M.C., Lebbink, R.J., Churchman, L.S., Ingolia, N.T., Patena, W.,
LeProust, E.M., Schuldiner, M., Weissman, J.S., and McManus, M.T. (2009).
Rapid creation and quantitative monitoring of high coverage shRNA libraries.
Nat. Methods 6, 443–445.
Bassik, M.C., Kampmann, M., Lebbink, R.J., Wang, S., Hein, M.Y., Poser, I.,
Weibezahn, J., Horlbeck, M.A., Chen, S., Mann, M., et al. (2013). A systematic
mammalian genetic interactionmap reveals pathways underlying ricin suscep-
tibility. Cell 152, 909–922.
Buckley, S.M., Aranda-Orgilles, B., Strikoudis, A., Apostolou, E., Loizou, E.,
Moran-Crusio, K., Farnsworth, C.L., Koller, A.A., Dasgupta, R., Silva, J.C.,
et al. (2012). Regulation of pluripotency and cellular reprogramming by the
ubiquitin-proteasome system. Cell Stem Cell 11, 783–798.
Buganim, Y., Faddah, D.A., Cheng, A.W., Itskovich, E., Markoulaki, S., Ganz,
K., Klemm, S.L., van Oudenaarden, A., and Jaenisch, R. (2012). Single-cell
expression analyses during cellular reprogramming reveal an early stochastic
and a late hierarchic phase. Cell 150, 1209–1222.
Calvete, J.J., Marcinkiewicz, C., Monleo´n, D., Esteve, V., Celda, B., Jua´rez, P.,
and Sanz, L. (2005). Snake venom disintegrins: evolution of structure and func-
tion. Toxicon 45, 1063–1074.
Chen, J., Liu, H., Liu, J., Qi, J., Wei, B., Yang, J., Liang, H., Chen, Y., Chen, J.,
Wu, Y., et al. (2013). H3K9 methylation is a barrier during somatic cell reprog-
ramming into iPSCs. Nat. Genet. 45, 34–42.
Chia, N.-Y., Chan, Y.-S., Feng, B., Lu, X., Orlov, Y.L., Moreau, D., Kumar, P.,
Yang, L., Jiang, J., Lau, M.-S., et al. (2010). A genome-wide RNAi screen
reveals determinants of human embryonic stem cell identity. Nature 468,
316–320.
Daley, G.Q. (2008). Common themes of dedifferentiation in somatic cell re-
programming and cancer. Cold Spring Harb. Symp. Quant. Biol. 73, 171–174.
Davis, R.L., Weintraub, H., and Lassar, A.B. (1987). Expression of a single
transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987–1000.
Golipour, A., David, L., Liu, Y., Jayakumaran, G., Hirsch, C.L., Trcka, D., and
Wrana, J.L. (2012). A late transition in somatic cell reprogramming requires
regulators distinct from the pluripotency network. Cell Stem Cell 11, 769–782.
Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., Farshid, G.,
Vadas, M.A., Khew-Goodall, Y., and Goodall, G.J. (2008). The miR-200 family
and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1
and SIP1. Nat. Cell Biol. 10, 593–601.
Gurdon, J.B., Elsdale, T.R., and Fischberg, M. (1958). Sexually mature individ-
uals of Xenopus laevis from the transplantation of single somatic nuclei. Nature
182, 64–65.
Handl, J., Kell, D.B., and Knowles, J. (2007). Multiobjective optimization in bio-
informatics and computational biology. IEEE/ACM Trans. Comput. Biol. Bioin-
formatics 4, 279–292.
Huang, W., Sherman, B.T., and Lempicki, R.A. (2009a). Bioinformatics enrich-
ment tools: paths toward the comprehensive functional analysis of large gene
lists. Nucleic Acids Res. 37, 1–13.
Igarashi, T., Araki, S., Mori, H., and Takeda, S. (2007). Crystal structures of
catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/ada-
malysin/reprolysin family proteins. FEBS Lett. 581, 2416–2422.
International Stem Cell Initiative, Adewumi, O., Aflatoonian, B., Ahrlund-
Richter, L., Amit, M., Andrews, P.W., Beighton, G., Bello, P.A., Benvenisty,
N., Berry, L.S., Bevan, S., et al. (2007). Characterization of human embryonic
stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25,
803–816.
Karpiuk, O., Najafova, Z., Kramer, F., Hennion, M., Galonska, C., Ko¨nig, A.,
Snaidero, N., Vogel, T., Shchebet, A., Begus-Nahrmann, Y., et al. (2012).
The histone H2B monoubiquitination regulatory pathway is required for differ-
entiation of multipotent stem cells. Mol. Cell 46, 705–713.
Kawamura, T., Suzuki, J., Wang, Y.V., Menendez, S., Morera, L.B., Raya, A´.,
Wahl, G.M., and Izpisu´a Belmonte, J.C. (2009). Linking the p53 tumour sup-
pressor pathway to somatic cell reprogramming. Nature 460, 1140–1144.
Ko¨nig, R., Chiang, C.-Y., Tu, B.P., Yan, S.F., DeJesus, P.D., Romero, A., Ber-
gauer, T., Orth, A., Krueger, U., Zhou, Y., and Chanda, S.K. (2007). A probabil-
ity-based approach for the analysis of large-scale RNAi screens. Nat. Methods
4, 847–849.
Li, Z., Yang, C.-S., Nakashima, K., and Rana, T.M. (2011). Small RNA-medi-
ated regulation of iPS cell generation. EMBO J. 30, 823–834.
Luo, B., Cheung, H.W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X.,
Hinkle, G., Boehm, J.S., Beroukhim, R., Weir, B.A., et al. (2008). Highly parallel
identification of essential genes in cancer cells. Proc. Natl. Acad. Sci. USA 105,
20380–20385.
Mangan, S., and Alon, U. (2003). Structure and function of the feed-forward
loop network motif. Proc. Natl. Acad. Sci. USA 100, 11980–11985.
Ohi, Y., Qin, H., Hong, C., Blouin, L., Polo, J.M., Guo, T., Qi, Z., Downey, S.L.,
Manos, P.D., Rossi, D.J., et al. (2011). Incomplete DNAmethylation underlies a
transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13,
541–549.
Onder, T.T., Kara, N., Cherry, A., Sinha, A.U., Zhu, N., Bernt, K.M., Cahan, P.,
Marcarci, B.O., Unternaehrer, J., Gupta, P.B., et al. (2012). Chromatin-modi-
fying enzymes as modulators of reprogramming. Nature 483, 598–602.Persaud, A., Alberts, P., Hayes, M., Guettler, S., Clarke, I., Sicheri, F., Dirks, P.,
Ciruna, B., and Rotin, D. (2011). Nedd4-1 binds and ubiquitylates activated
FGFR1 to control its endocytosis and function. EMBO J. 30, 3259–3273.
Polo, J.M., Anderssen, E., Walsh, R.M., Schwarz, B.A., Nefzger, C.M., Lim,
S.M., Borkent, M., Apostolou, E., Alaei, S., Cloutier, J., et al. (2012). A molec-
ular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617–
1632.
Qin, H., Blaschke, K., Wei, G., Ohi, Y., Blouin, L., Qi, Z., Yu, J., Yeh, R.F.,
Hebrok, M., and Ramalho-Santos,M. (2012). Transcriptional analysis of plurip-
otency reveals the Hippo pathway as a barrier to reprogramming. Hum. Mol.
Genet. 21, 2054–2067.
Ramalho-Santos, M. (2009). iPS cells: insights into basic biology. Cell 138,
616–618.
Rodin, S., Domogatskaya, A., Stro¨m, S., Hansson, E.M., Chien, K.R., Inzunza,
J., Hovatta, O., and Tryggvason, K. (2010). Long-term self-renewal of human
pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol.
28, 611–615.
Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T.A., Datti,
A., Woltjen, K., Nagy, A., and Wrana, J.L. (2010). Functional genomics reveals
a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic
cell reprogramming. Cell Stem Cell 7, 64–77.
Scita, G., and Di Fiore, P.P. (2010). The endocytic matrix. Nature 463, 464–473.
Subramanyam, D., Lamouille, S., Judson, R.L., Liu, J.Y., Bucay, N., Derynck,
R., and Blelloch, R. (2011). Multiple targets of miR-302 and miR-372 promote
reprogramming of human fibroblasts to induced pluripotent stem cells. Nat.
Biotechnol. 29, 443–448.
Tada, M., Tada, T., Lefebvre, L., Barton, S.C., and Surani, M.A. (1997). Embry-
onic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid
cells. EMBO J. 16, 6510–6520.
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells
from mouse embryonic and adult fibroblast cultures by defined factors. Cell
126, 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K.,
and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 131, 861–872.
Tan, T.Z., Miow, Q.H., Huang, R.Y.-J., Wong, M.K., Ye, J., Lau, J.A., Wu, M.C.,
Bin Abdul Hadi, L.H., Soong, R., Choolani, M., et al. (2013). Functional geno-
mics identifies five distinct molecular subtypes with clinical relevance and
pathways for growth control in epithelial ovarian cancer. EMBO Mol Med 5,
983–998.
von Kleist, L., Stahlschmidt, W., Bulut, H., Gromova, K., Puchkov, D., Robert-
son, M.J., MacGregor, K.A., Tomilin, N., Pechstein, A., Chau, N., et al. (2011).
Role of the clathrin terminal domain in regulating coated pit dynamics revealed
by small molecule inhibition. Cell 146, 471–484.
Wei, X., Moncada-Pazos, A., Cal, S., Soria-Valles, C., Gartner, J., Rudloff, U.,
Lin, J.C., Rosenberg, S.A., Lo´pez-Otı´n, C., and Samuels, Y.; NISC Compara-
tive Sequencing Program (2011). Analysis of the disintegrin-metalloprotei-
nases family reveals ADAM29 and ADAM7 are often mutated in melanoma.
Hum. Mutat. 32, E2148–E2175.
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L.,
Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced
pluripotent stem cell lines derived from human somatic cells. Science 318,
1917–1920.
Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou,
P., Song, Z., et al. (2008). Two supporting factors greatly improve the efficiency
of human iPSC generation. Cell Stem Cell 3, 475–479.
Zuberi, K., Franz, M., Rodriguez, H., Montojo, J., Lopes, C.T., Bader, G.D., and
Morris, Q. (2013). GeneMANIA prediction server 2013 update. Nucleic Acids
Res. 41 (Web Server issue), W115–W122.Cell 158, 449–461, July 17, 2014 ª2014 Elsevier Inc. 461
